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The oxidative stress is an accompanying process 
in a number of pathologies [1, 2]. This event is elicited 
by increased concentration of the reactive oxygen 
species (ROS), which induce damage of DNA, protein 
oxidation and lipids peroxidation. The cause-result re-
lation between oxidative stress and specific disease is 
not elucidated so far. It is unclear if excess production 
of ROS represents one of the factors of pathology de-
velopment, or, contrariwise, a disease elicits oxidative 
stress, as one of destructive processes accompanying 
a pathophysiological condition. In the last years the 
protective role of ROS became actual [3]. However, 
oxidative stress accompanied with lipid peroxidation 
are still viewed as a precursor of many kinds of patholo-
gy — atherosclerosis, diabetes, neurodegenerative 
diseases and, finally, carcinogenesis. In the latter case 
DNA interaction with ROS might play a critical role in 
malignant transformation of the cells. An oxidative 
stress occurs in different kinds of tumors, and is con-
sidered among the causes of carcinogenesis [4].
An oxidative stress occurring during tumor growth 
is reflected on content and activity of the antioxidants, 
including blood antioxidant enzymes: SOD [5], CAT [6], 
Cp [7, 8], GSH and GSH-dependent system, which 
encompasses GR, GSH-Px and GT [9]. The alteration 
displayed by the antioxidant enzymes depend on type 
and differentiation grade of tumor [10].
The aim of our investigation was to study the state 
of blood AOS in patients with BHP and CaP.
MATERIALS AND METHODS
Erythrocytes isolation.The blood plasma and 
erythrocytes of the patients (before therapy) with 
BHP (n = 15) and CaP (n = 15) were studied. The 
patients were 60–75 years old, with primary tumors. 
The control group consisted from 15 healthy males of 
similar age. The material was obtained and diagnosis 
was estimated by the Georgian National Center of 
Urology by means of rectal, histological, and echo-
graphic examination of the prostate. The erythrocytes 
and plasma were isolated from 10 ml of vein blood by 
routine procedure [10]. The study was approved by 
the Ethical committee of the institute and informed 
consent was obtained from each patient.
Enzymes activity and content evaluation. 
Analysis of SOD activity was performed routinely as 
described in [11] and expressed in U/µl. The stan-
dard samples for all given enzymes (except Cp) 
were obtained from Sigma Chemical Co. CAT activ-
ity was analyzed with the use of hydrogen peroxide 
(AO “CHIMPROM”) and expressed in mcat/ml [12].
For evaluation of Cp plasma content modified 
Ravin method was used [13]. It implies Cp-induced 
oxidation of the p-phenylenediamine dihydrochlo-
ride (p-PDA, Lancaster). Cp content is expressed in 
mg/% [13]. GSH content was evaluated by standard 
approach using dithionitrobenzoic acid (DTNB), and 
expressed in µM/l [14]. GSH-Px activity was evaluated 
as described [10] and expressed in micromols/1 g of 
hemoglobin/minute.
Activity of GR was assessed by routine technique 
[10] and expressed in micromols/1g hemoglobin/
minute. Lipid peroxidation was evaluated using thio-
barbituric acid (TBA-test) and expressed as amount of 
malondialdehyde (MDA) (μM/L plasma) [15].
ACTIVITY AND CONTENT OF ANTIOXIDANT ENZYMES 
IN PROSTATE TUMORS
N. Kotrikadze1, *, M. Alibegashvili1, M. Zibzibadze1, N. Abashidze1, T. Chigogidze2, L. Managadze2, K. Artsivadze1
1Faculty of Exact and Natural Sciences, Institute of Biology, Iv. Javakhishvili Tbilisi State University, 
Tbilisi, Georgea
2Faculty of Medicine, Institute of Urology, Tbilisi, Georgea
Aim: To investigate the antioxidant enzyme system in blood of men with benign hyperplasia of prostate (BHP) and with prostate ade­
nocarcinoma (CaP). Methods: The spectrophotometrical methods were applied to study content and activity changes of superoxide­
dismutase (SOD), catalase (CAT), ceruloplasmin (Cp), tripeptide glutathione (GSH), glutathione­peroxidase (GSH­Px), and 
glutathione­reductase (GR). Lipid peroxidation was evaluated using thiobarbituric acid (TBA)­test. Blood plasma and erythrocytes 
of men with prostate tumors served as the material for the studies; n = 15 for each group. Results: SOD activity was increased in BHP 
(24.65 ± 1.20 U/μl) and decreased in CaP (11.45 ± 0.89 U/μl), CAT activity remained unaltered in BHP (12.41 ± 0.85 mcat/ml) and 
was slightly declined in CaP (9.52 ± 0.56 mcat/ml). Cp was increased in both kind of tumors, especially in CaP (54.27 ± 7.22 mg%), 
as well as GSH (0.736 ± 0.07 μM/l) and GR (0.031 ± 0.002 μM/g.Hemogl/min). GSH­Px was sharply increased in BHP 
(0.67 ± 0.05 μM/g.Hemogl/min) and reduced in CaP (0.16 ± 0.01 μM/g.Hemogl/min). Conclusion: The development of BHP reflects 
relatively weakly on blood system as activity and content of antioxidant enzymes are not revealing marked changes in this disease. The 
significant changes are revealed in case of CaP, showing the reduced functional state of blood antioxidant enzyme system. 
Key Words: benign prostate hyperplasia, prostate adenocarcinoma, oxidative stress, antioxidant enzymes.
Received: April 8, 2007. 
*Correspondence: E-mail: nana@biomed.ge 
Abbreviations used: BHP — benign prostate hyperplasia; 
CaP — prostate adenocarcinoma; ROS — reactive oxygen spe-
cies; AOS — antioxidant system; SOD — superoxide-dismutase; 
CAT — catalase; Cp — ceruloplasmin; GSH — reduced glutathione; 
GSH-Px — glutathione-peroxidase; GR — glutathione-reductase; 
GT — glutathione-transferase; MDA — malondialdehyde.
Exp Oncol 2008
30, 3, 244–247
Experimental Oncology 30, 244–247, 2008 (September) 245
Statistical analysis. Experimental data were 
processed by means of standard variation statistics 
MINITAB (Basic statistic), P ≤ 0.05 was considered as 
statistically significant.
RESULTS AND DISCUSSION
Investigation have shown that in case of BHP inten-
sification of lipid peroxidation occured as evidenced by 
increased MDA content by ~ 1.5-times and in CaP — by 
~ 2.6-times (Table 1), compared with control group, 
pointing the intensified free radical processes.
Table 1. Alterations of lipid peroxidation and antioxidant enzymes: super-
oxide-dismutase (SOD), catalase (CAT) and ceruloplasmin (Cp) levels in 
blood of patients with prostate tumors
SOD
In erythrocytes
U/μl
CAT
In erythrocytes
mcat/ml
Cp
In plasma
mg%
MDA
In plasma
μM/L
Control group 18.73 ± 1.05 12.98 ± 1.02 25.55 ± 1.22 0.80 ± 0.07
BHP 24.65 ± 1.20
P < 0.001
12.41 ± 0.85
P > 0.05
32.09 ± 1.61
P < 0.01
1.21 ± 0.02
P < 0.0001
CaP 11.45 ± 0.89
P < 0.0001
9.52 ± 0.56
P < 0.01
54.27 ± 7.22
P < 0.001
2.09 ± 0.01
P < 0.0001
Notes: values expressed as means ± SEM; P value is given vs control group; 
n = 15 of patients in each group.
The studies of the SOD activity in the blood 
erythrocytes have shown that increase of SOD 
activity was sharply manifested in case of BHP 
(~ 1.3-times, P < 0.001), compared with the control 
group (see Table 1), while in CaP, activity of the en-
zyme decreases versus control group (~ 1.6-times, 
P < 0.0001) and BHP (~ 2.2-times, P < 0.0001). The 
CAT activity in the blood erythrocytes remained practi-
cally unaltered in BHP group (see Table 1), while in the 
erythrocytes of the patients with CaP, well manifested 
decrease of its activity occurred compared with the 
control group (~ 1.4-times, P < 0.01; see Table 1). Our 
studies have also shown that in conditions of BHP, in 
70% of the patients, concentration of Cp in the blood 
plasma remains within normal range, while the mean 
index of Cp approaches the upper limit of normal level 
and is 32.09 ± 1.61 mg/% (P < 0,01, see Table 1). In the 
CaP group, two-fold increase of the Cp concentration 
occurred versus normal level — 54.27 ± 7.22 mg/% 
(P < 0.001). 
Investigation of the GSH-dependent system re-
vealed that the amount of the GSH in erythrocytes of 
the patients with prostate tumors, sharply increased in 
both, BHP (~ 1.8-times, P < 0.01) and CaP (~ 4-times, 
P < 0.0001) groups, as compared with the control 
group (Table 2). The GSH-Px activity sharply increased 
in BHP, as compared with the erythrocytes in both the 
control group (P < 0.0001) and CaP (see Table 2). In 
contrary, in a case of CaP activity of the enzyme de-
creased twice versus the control group (P < 0.0001)
and ~ 4-times versus BHP group. Investigation of the 
GR activity in the blood of prostate tumor patients 
showed that it tends to elevate in parallel with aggra-
vation of the disease (P = 0.0001 for BHP, P < 0.0001 
for CaP, see Table 2). 
Increase of SOD activity during BHP points at mo-
bilization of AOS, resulted in increased production of 
the enzyme. Sharp decrease of SOD activity during 
CaP shows the contrary event — antioxidant defence 
is evidently weakened during malignant transforma-
tion of prostate. A direct cause of decreased activity 
of SOD in the erythrocytes may be the excess of the 
superoxide radicals, resulted in SOD consumption, or 
the accumulation of hydrogen peroxide, inducing the 
inhibition of the enzyme. 
Table 2. Alterations of glutathione-dependent enzymes (GSH-Px and GR) 
activity, and reduced glutathione (GSH) content in erythrocytes of patients 
with prostate tumors
GSH-Px 
μM/g.Hemogl/min
GR 
μM/g.Hemogl/min
GSH
μM /l
Control group 0.32 ± 0.03 0.008 ± 0.002 0.184 ± 0.02
BHP 0.67 ± 0.05
P < 0.0001
0.019 ± 0.001
P = 0.0001
0.336 ± 0.05
P < 0.01
CaP 0.16 ± 0.01
P < 0.0001
0.031 ± 0.002
P < 0.0001
0.736 ± 0.07
P < 0.0001
Notes: values expressed as means ± SEM; P value is given vs control group; 
n = 15 of patients in each group.
An unequivocal increase of SOD without CAT in-
crease in BHP group, may be a reason for accumula-
tion of the hydrogen peroxide, and thus for aggravation 
of the oxidating stress (see Table 1). Respectively, 
it may serve as one of the causes for benign tumor 
transformation into the malignant one. Alteration 
of CAT, in case of hormone-dependent tumors, are 
unpredictable [16]. Decrease of CAT activity in eryth-
rocytes during CaP, points at functional decrease of 
AOS as well as in case of SOD and it should be due 
to increased volume of the hydrogen peroxide during 
the clear intensification of lipids peroxidation. Another 
possible mechanisms of CAT activity attenuation du-
ring CaP, may be the increase of the lysosomal acidic 
phosphatase in blood [17], because the lysosomal 
enzymes, especially the acidic phosphatase, are able 
to influence the CAT activity and induce its inhibition. 
Despite the elevation of the oxidative processes 
Cp content is increased in parallel with aggravation of 
disease (see Table 1), that arises from the fact that Cp 
belongs to the acute-phase proteins [18]. Biosynthesis 
of Cp represents a compensatory-adaptive response of 
an organism challenged by pathology. Therefore, ex-
clusively high content of the Cp in the blood during the 
CaP should be caused by especially increased demand 
for Cp as for the main blood antioxidant. Furthermore, 
the hormonal shifts occuring in prostate tumors, may 
represent one of the possible reasons of Cp content 
changes. Influence of estradiol results in increased 
biosynthesis of Cp in the liver at the transcription level, 
therefore elevated level of estradiol which takes place in 
prostate tumors, as hormone-dependent tumors may 
induce increase of Cp amount in the blood. 
Being a major intracellular antioxidant GSH acts as 
a strong antitoxicant conjugating toxic compounds, 
cytostatics, carcinogens, mutagens, drugs and etc; 
[9]. Therefore, the increase of GSH along with disease 
aggravation, is the defence reaction directed to the 
cell protection from oxidizing stress and impact of 
toxic substances. One of additional causes of GSH 
concentration growth during prostate tumors might 
be increased proliferation of the tumor cells, since 
glutathione system controls the cell cycle and its con-
centration increases in parallel with cellular prolifera-
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tion [9]. The steroid hormones, especially estrogens, 
promote the growth of GSH content and GR activity 
as well [19].
GSH-Px fulfills detoxication of hydrogen per oxide 
and lipid hydroperoxides together with GSH and 
GR, that increases stability of erythrocytes against 
hemolysis [20, 21]. In BHP group the sharp increase 
of GSH-Px activity indicates the counteraction of AOS 
against developed benign tumor. In case of CaP re-
duced activity of the enzyme precisely shows a state 
of AOS. As to GR, its increased activity in both types of 
tumors must be due to increased demand for reduced 
glutathione, i. e. must represent a compensatory reac-
tion of an organism, which is important in maintenance 
of resistance of erythrocytes against oxidizing stress 
and hemolysis.
Alteration of the antioxidant enzymes level has 
the common trend: in conditions of benign tumor 
their variability is not manifested markedly and is 
directed to recover the normal defence, while in case 
of malignization sharp and often incurable changes 
are observed almost for all enzymes. The develop-
ment of BHP reflects relatively weakly on an organism 
blood system and the mechanisms of the antioxidant 
defence still show coordinated, balanced interac-
tion. The significant changes revealed in case of CaP 
indicate the reduced functional state of blood AOS. 
Decreased activity of SOD and GSH-Px reflects de-
structive processes occurring in blood during malig-
nant transformation when the blood AOS cann’t fulfill 
effective defence, while increased activity of Cp, GSH 
and GR represents a compensatory response against 
the aggravation of pathology.
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СОДЕРЖАНИЕ И АКТИВНОСТЬ АНТИОКСИДАНТНЫХ ФЕРМЕНТОВ 
У ПАЦИЕНТОВ С ОПУХОЛЯМИ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ
Цель: исслед�вание системы анти�ксидантных фермент�в в кр�ви б�льных c д�бр�качественн�й гиперплазией пр�статы 
(ДГП) и аден�карцин�м�й пр�статы (А�П). Методы: изменения с�держания и активн�сти супер�ксид­дисмутазы (СОД), 
каталазы (�АТ), церул�плазмина (ЦП), трипептида глютати�на (ВГ), глутати�н­пер�ксидазы (ГП) и глутати�н­редуктазы 
(ГР) были изучены спектр�ф�т�метрическими мет�дами. Перекисн�е �кисление липид�в �ценивали с п�м�щью ти�барби­
тур�в�й кисл�ты (TB�­тест). �атериал�м для исслед�вании служили плазма кр�ви и эритр�циты б�льных с �пух�лями 
пр�статы, n = 15 для кажд�й группы. Результаты: активн�сть СОД п�вышалась в ДГП (24,65 ± 1,20 ед./мкл) и сни­
жалась в А�П (11,45 ± 0,89 ед./мкл). Активн�сть �АТ �ставалась неизмененн�й в ДГП (12,41 ± 0,85 мкат/мл) и слегка 
снижалась в А�П (9,52 ± 0,56 мкат/мл). С�держание ЦП п�вышал�сь в �б�их типах �пух�лей, в �с�бенн�сти в А�П 
(54,27 ± 7,22 mg%), так же как ВГ (0,736 ± 0,07 мкM/л) и ГР (0,031 ± 0,002 мк�/г.гем�гл/мин). Активн�сть ГП резк� 
в�зрастала в ДГП (0,67 ± 0,05 мк�/г.гем�гл/мин) и снижалась в А�П (0,16 ± 0,01 мк�/г.гем�гл/мин). Выводы: развитие 
ДГП сравнительн� слаб� �тражается на системе кр�ви, так как с�держание и активн�сть анти�ксидантных фермент�в 
не п�казывают заметных изменении при эт�й б�лезни. Значительные изменения были выявлены в группе б�льных с А�П, 
чт� указывал� на п�давление функци�нальн�г� с�ст�яния системы анти�ксидантных фермент�в кр�ви. 
Ключевые слова: д�бр�качественная гиперплазия предстательн�й железы, аден�карцин�ма предстательн�й железы, 
�ксидативный стресс, анти�ксидантные ферменты.
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